| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |